Clinical Trials on Dermatitis, Seborrheic in Australia
Total 156 results
-
PeplinCompletedSeborrheic KeratosisAustralia
-
Clinuvel Pharmaceuticals LimitedCompletedPolymorphic Light Eruption (PLE)Austria, Australia, United Kingdom
-
Vyne Therapeutics Inc.CompletedAtopic DermatitisUnited States, Australia
-
Novartis PharmaceuticalsCompletedAtopic DermatitisSouth Africa, Belgium, Germany, Australia, Netherlands, Bulgaria, Austria, Romania
-
Murdoch Childrens Research InstituteSuspended
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedAtopic Dermatitis (AD)Australia
-
Stratpharma AGCompletedRadiation DermatitisAustralia
-
Biosion, Inc.Southern Star Research Pty Ltd.CompletedAtopic DermatitisAustralia
-
Hoth Therapeutics, Inc.Novotech (Australia) Pty LimitedCompleted
-
Apeiron BiologicsCompleted
-
Nanjing Immunophage Biotech Co., LtdNovotech (Australia) Pty LimitedNot yet recruiting
-
PfizerCompletedDermatitis, AtopicAustralia
-
PfizerCompletedDermatitis, AtopicAustralia, United States
-
Murdoch Childrens Research InstituteMonash UniversityCompletedDermatitis, AtopicAustralia
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAtopic DermatitisPoland, United States, Australia
-
Medical University of GrazAustrian Science Fund (FWF)TerminatedPolymorphic Light EruptionAustria
-
Medical University of GrazCompletedPolymorphic Light EruptionAustria
-
Medical University of GrazCompleted
-
RDC Clinical Pty LtdCompleted
-
ASLAN PharmaceuticalsCompleted
-
LEO PharmaCompletedAtopic DermatitisAustria
-
Medical University of ViennaCompleted
-
Medical University of GrazRecruiting
-
Regeneron PharmaceuticalsSanofiCompletedAtopic DermatitisGermany, New Zealand, Australia
-
LEO PharmaCompleted
-
Stefan WoehrlMedical University of ViennaCompletedAtopic DermatitisAustria
-
Johannes Kepler University of LinzRecruitingKeratitis Bacterial | Keratitis FungalAustria
-
Medical University of GrazCompletedPsoriasis | Atopic Eczema | Polymorphic Light EruptionAustria
-
Medical University of ViennaCompleted
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Korea, Republic of, Poland, Italy, Germany, Argentina, Austria, Japan, Taiwan
-
Astellas Pharma IncCompletedAtopic DermatitisAustralia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Switzerland, Israel, Korea, Republic of, Japan, Poland, Argentina, Austria, Hungary
-
Technische Universität DresdenCompleted
-
Novartis PharmaceuticalsCompletedAtopic DermatitisGermany, Austria, France
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
PfizerCompletedAtopic DermatitisUnited States, Canada, Australia, Germany, Hungary
-
Siolta Therapeutics, Inc.Active, not recruitingAtopic Dermatitis | Type 1 HypersensitivityUnited States, Australia, Puerto Rico
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
PfizerAvailableAtopic DermatitisTaiwan, United States, Australia, Austria, Belgium, Canada, Greece, Mexico, Netherlands, Russian Federation, Spain, Switzerland
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Finland, Germany, Japan, Netherlands, Spain
-
Bristol-Myers SquibbCompletedDermatitis, AtopicGermany, Australia, Poland, Canada, Austria, United States, Spain
-
Eli Lilly and CompanyDermira, Inc.CompletedAtopic DermatitisUnited States, Canada, Australia, Poland
-
University of MelbourneActive, not recruitingAsthma | Eczema | Allergy;FoodAustralia
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisFrance, United States, Australia, Germany, Israel, Italy, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
Premier Specialists, AustraliaSteritasActive, not recruitingGlucocorticoids Toxicity | Autoimmune Bullous DermatosisAustralia
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada